Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
ArcelorMittal (NYSE: MT) shares declined 1.56 percent to close at $13.90 a share Thursday. The stock traded between $13.40 and $13.94 on volume of 7.49 million shares traded. Analysts at B. Riley have recently initiated coverage on the company with an “underweight” rating. Shares of ArcelorMittal have fallen approximately 20.0 percent year-to-date.
Find out more about ArcelorMittal including full access to the free equity report at:
www.RDInvesting.com/MT
Quantum Fuel Systems Tech Worldwide Inc. (NASDAQ: QTWW) shares declined 3.80 percent to close at $3.80 a share Thursday. The stock traded between $2.11 and $2.56 on volume of 524,097 shares traded. Analysts at Ascendiant recently initiated coverage on the company with a “strong buy” rating. Shares of Quantum have gained approximately 3.5 percent year-to-date.
Find out more about Quantum including full access to the free equity report at:
www.RDInvesting.com/QTWW
Sigma-Aldrich Corporation (NASDAQ: SIAL) shares declined 1.03 percent to close at $84.40 a share Thursday. The stock traded between $84.00 and $85.26 on volume of 565,605 shares traded. Analysts at Janney Capital have recently initiated coverage on the company with a “buy” rating. Shares of Sigma-Aldrich have gained approximately 15.0 percent year-to-date.
Find out more about Sigma-Aldrich including full access to the free equity report at:
www.RDInvesting.com/SIAL
Thermo Fisher Scientific Inc. (NYSE: TMO) shares declined 0.83 percent to close at $91.30 a share Thursday. The stock traded between $90.96 and $91.75 on volume of 1.34 million shares traded. Analysts at Janney have recently initiated coverage on the company with a “buy” rating. Shares of Thermo Fisher Scientific have gained approximately 43.0 percent year-to-date.
Find out more about Thermo Fisher Scientific including full access to the free equity report at:
www.RDInvesting.com/TMO
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Research Driven Investing
info@rdinvesting.com